Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 22;24(10):9081.
doi: 10.3390/ijms24109081.

Targeted Radionuclide Therapy of Cancer and Infections

Bart C H van der Wal  1 , Ekaterina Dadachova  2
Affiliations
Editorial

Targeted Radionuclide Therapy of Cancer and Infections

Bart C H van der Wal et al. Int J Mol Sci. .

Abstract

Targeted radionuclide therapy (TRT) has been burgeoning worldwide, with several radiopharmaceuticals for the treatment of metastatic cancers being approved for clinical use [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Li Y., Chyan M.K., Hamlin D.K., Nguyen H., Corey E., Wilbur D.S. Oxidation of p-[125I]Iodobenzoic Acid and p-[211At]Astatobenzoic Acid Derivatives and Evaluation In Vivo. Int. J. Mol. Sci. 2022;23:10655. doi: 10.3390/ijms231810655. - DOI - PMC - PubMed
    1. Delbart W., Karabet J., Marin G., Penninckx S., Derrien J., Ghanem G.E., Flamen P., Wimana Z. Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy. Int. J. Mol. Sci. 2022;23:12369. doi: 10.3390/ijms232012369. - DOI - PMC - PubMed
    1. Sreekumar S., Zhou D., Mpoy C., Schenk E., Scott J., Arbeit J.M., Xu J., Rogers B.E. Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. Int. J. Mol. Sci. 2023;24:3083. doi: 10.3390/ijms24043083. - DOI - PMC - PubMed
    1. Allen K.J.H., Malo M.E., Jiao R., Dadachova E. Targeting Melanin in Melanoma with Radionuclide Therapy. Int. J. Mol. Sci. 2022;23:9520. doi: 10.3390/ijms23179520. - DOI - PMC - PubMed
    1. Van Nuland M., Ververs T.F., Lam M.G.E.H. Dosing Therapeutic Radiopharmaceuticals in Obese Patients. Int. J. Mol. Sci. 2022;23:818. doi: 10.3390/ijms23020818. - DOI - PMC - PubMed

Publication types

MeSH terms